Protocol Ledger

NCT05317858 · Phase III · RECRUITING

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Interventional Phase III clinical trial protocol NCT05317858 sponsored by InSightec in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-08-12 Enrollment: 96 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05317858
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)96 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05317858
Protocol FieldVerified Registry Value
NCT IdentifierNCT05317858
Consolidated Lead SponsorInSightec
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment96 participants (ESTIMATED)
Registered Start Date2022-08-12
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05317858
Hospital Research SiteLocationSite Profile
Hoag Memorial Hospital PresbyterianNewport Beach, CAOpen Hospital Dossier ->
Moffitt Cancer CenterTampa, FLOpen Hospital Dossier ->
University of MarylandBaltimore, MDOpen Hospital Dossier ->
Duke University Medical CenterDurham, NCOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI